Mandolin raises $40M to automate access to life-saving medicines

Mandolin has announced a funding round, raising $40 million to enhance its platform that facilitates access to specialty medications. The company aims to reduce the administrative burden associated with obtaining these necessary drugs.

Key Highlights

• Funding Amount: $40 million
• Purpose: Automate access to life-saving medicines
• Goal: Streamline the process to reduce paperwork and speed up access for patients.

Background

Mandolin develops technology designed to streamline the complicated process involved in the acquisition of specialty drugs, aiming to make it easier for both healthcare providers and patients.

For more information, visit Mandolin's official page.